Study presented at the European Societ... - Lung Cancer Support

Lung Cancer Support

4,050 members2,201 posts

Study presented at the European Society for Medical Oncology (ESMO) Congress may mean a new way to treat patients with stage 3 lung cancer

MFH_Advocate profile image
5 Replies

This past week, results of some key studies were presented at a major meeting in Spain. One study, called the PACIFIC trial, could change the way that patients with stage 3 lung cancer are treated. The study showed that patients with stage 3 lung cancer who took an immunotherapy drug (durvalumab, brand name Imfinzi) after chemotherapy and radiation had a longer period of progression-free survival (16.8 months) than patients who were not treated with immunotherapy (5.6 months). The results for overall survival are not yet available. Durvalumab is a PD-L1 inhibitor that is not yet FDA approved for lung cancer. onclive.com/conference-cove...

Written by
MFH_Advocate profile image
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
5 Replies
JeanE41 profile image
JeanE41

This certainly sounds hopeful. It expands the potential treatments. I hope it is approved and can be added to the arsenal currently available to us.

Jean

judg69 profile image
judg69

Great news. I would add however, that very occasionally only, a surgeon may still do surgery with level III AB . I am witness to this , and still alive after 5 years and 3 months! Moral is Do Not Ever Give Up! Kind Regards, judg69

MFH_Advocate profile image
MFH_Advocate in reply to judg69

judg69 Thank you so much for sharing this! It is very important to know that surgery can be possible for some patients. Great to hear that you are an example of this!

Denzie profile image
DenzieModeratorVolunteer

Thanks for sharing this. There's so much going on trialwise it's hard to keep up.

scifiknitter profile image
scifiknitterBlogger

Oncologists seem to be very excited by this - one said it's the first change in standard of care for stage 3 in 15 years.

Not what you're looking for?

You may also like...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...

Has anyone received the Covid-19 Vaccine while taking Immunotherapy?

Fellow cancer patients, I have been very concerned about how my immunotherapy (Opdivo/nivolumab)...

What It's Like to Be in a Lung Cancer Clinical Trial - Part One, Background Information

Have you ever thought about participating in a lung cancer clinical trial? The thought of taking an...

Stage 4 adenocarcinom

My husband was diagnosed with adenocarcinoma stage 4 nsc lung cancer poorly differentiated. He had...

Lung cancer? Me? No way.......

A few months ago if you would have asked me to list 10 things from which I might die, I would have...